Arabian International Healthcare Holding Valuation
Is 9530 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Earnings gegen Gleichaltrige
Price-To-Earnings gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of 9530 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: 9530 (SAR40) wird unter unserer Schätzung des Fair Value (SAR76.61) gehandelt.
Deutlich unter dem Marktwert: 9530 wird um mehr als 20 % unter dem Marktwert gehandelt.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 9530?
Other financial metrics that can be useful for relative valuation.
What is 9530's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ر.س837.12m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.8x |
Enterprise Value/EBITDA | 18.2x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does 9530's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 26.5x | ||
9574 Professional Medical Expertise | 11.4x | n/a | ر.س262.5m |
2230 Saudi Chemical Holding | 33.7x | n/a | ر.س6.2b |
9572 Al-Razi Medical | 39x | n/a | ر.س79.6m |
9546 Naba Al Saha Medical Services | 21.8x | n/a | ر.س855.8m |
9530 Arabian International Healthcare Holding | 35.4x | n/a | ر.س837.1m |
Price-To-Earnings gegen Gleichaltrige: 9530 ist auf der Grundlage des Price-To-Earnings Verhältnisses (33.5x) im Vergleich zum Durchschnitt der Vergleichsgruppe (26.9x) teuer.
Price to Earnings Ratio vs Industry
How does 9530's PE Ratio compare vs other companies in the Asian Healthcare Industry?
Price-To-Earnings gegen Industrie: 9530 ist teuer, wenn man sein Price-To-Earnings Verhältnis (33.5x) mit dem Asian Healthcare Branchendurchschnitt (23.8x) vergleicht.
Price to Earnings Ratio vs Fair Ratio
What is 9530's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 35.4x |
Fair PE Ratio | n/a |
PM vs. Fair Ratio: Unzureichende Daten zur Berechnung der Price-To-Earnings Fair Ratio von 9530 für die Bewertungsanalyse.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analysten-Prognose: Unzureichende Daten für eine Preisprognose.